When I profiled Millennium Pharmaceuticals' chief scientific officer, Joe Bolen, in last month's issue of __The Scientist,__ he described some amusing airport foibles ...
On March 13, Protein Design Labs (PDL; Fremont, CA) agreed to license its “humanization” technology to Millennium Pharmaceuticals (Cambridge, MA) for transforming mouse monoclonal antibodies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback